References
- Coburn JW et al: Medical treatment in primary and secondary hyperparathyroidism. Semin Drug Treat 2:117–135, 1972
- Singer FR et al: An evaluation of antibodies and clinical resistance to salmon calcitonin. J Clin Invest 51:2331–2338, 1972
- Dube WJ et al: Hyperparathyroidism secondary to long-term therapy of Paget's disease of bone with calcitonin. In Talmage RV, Munson PL (Editors): Calcium, Parathyroid Hormone and the Calcitonins. New York, Excerpta Medica, 1972, pp 113–115
- Kofman S, Eisenstein R: Mithrainycin in the treatment of disseminated cancer. Cancer Chemother Rep 32:77–96, 1963
- Perlia CP et al: Mithramycin treatment of hypercalcemia. Cancer 25:389–394, 1970
- Laake H: The action of corticosteroid on the renal reabsorption of calcium. Acta Endocrinol 34:60–64, 1960
- Harrison HE, Harrison HC: Transfer of Ca45 across intestinal wall in vitro in relation to action of vitamin D and Cortisol. Am J Physiol 199:265–271, 1960
- Peck WA et al: Regulation of pyrimidine ribonucleoside incorporation in isolated bone cells. J Biol Chem 246:4439–4446, 1971
- Gallagher JC, Nordin BE: Treatment with estrogens of primary hyperparathyroidism in post-menopausal women. Lancet 1:503–507, 1972
- Bulger HA et al: Functional pathology of hyperparathyroidism. J Clin Invest 9:143–190, 1930
- Yendt ER: Disorders of calcium, phosphorus, and magnesium metabolism. In Maxwell MH, Kleeman CR (Editors): Clinical Disorders of Fluid and Electrolyte Metabolism. New York, McGraw-Hill Book Co. 1972, pp 416–417
- Lee DB et al: The pathophysiology and clinical aspects of hypercalcemic disorders. West J Med 129:278–320, 1978
- Carey RW et al: Massive extraskeletal calcification during phosphate treatment of hypercalcemia. Arch Intern Med 122:150–155, 1968
- Aurbach GD et al: Hyperparathyroidism: Recent studies. Ann Intern Med 79:566–581, 1973